 Results from KARE Phase 2 Trial of Oral KORSUVATM in Atopic Dermatitis Patients with Moderate-to-Severe Pruritus to be presented Results from KARE Phase 2 Trial of Oral KORSUVATM in Atopic Dermatitis Patients with Moderate-to-Severe Pruritus to be presented 